Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial

Cardiovasc Drugs Ther. 2021 Oct;35(5):1079-1081. doi: 10.1007/s10557-021-07212-z. Epub 2021 Jun 8.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Docosahexaenoic Acids / therapeutic use
  • Dose-Response Relationship, Drug
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / therapeutic use*
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / prevention & control*
  • Randomized Controlled Trials as Topic

Substances

  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid